Technology | Radiation Dose Management | May 23, 2019

Radiation reduction technology integrates directly into mobile C-arms

ControlRad Announces FDA Clearance and Launch of ControlRad Trace

May 23, 2019 — ControlRad Inc. announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its ControlRad Trace and the company has initiated its commercial launch. The ControlRad Trace is the only technology, according to the company, that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure.

“Radiologists and our teams have grave concerns about the long-term effects from radiation exposure,” said John A. Carrino, M.D., MPH, vice chairman of radiology, Hospital for Special Surgery. “I am excited that new technology for mobile C-arms is now available because it has the potential to drastically improve our radiation safety while maintaining image quality so we can continue to effectively diagnose and treat our patients. I believe these new products should become the standard of care for fluoroscopic procedures.”

Fluoroscopically guided procedures (FGP) with C-arms have allowed for major advances in treating countless diseases. However they expose patients and medical staff to ionizing radiation, which may increase a person’s lifetime risk of developing cancer.1 For example, an interventional fluoroscopy procedure is roughly equivalent to the adult effective dose of between 250-3,500 chest X-rays.2

With its proprietary semi-transparent filter, tablet and image processing technology, the ControlRad Trace solution can be retrofitted on existing C-arms, reducing the barrier to adopting the technology in order to reduce unnecessary radiation up to 89 percent,3 without compromising image quality in the region of interest (ROI) and overall workflow. The medical staff draws an ROI on a ControlRad tablet, which in real time optimizes image quality in the ROI while reducing unnecessary radiation in the periphery.

For more information: www.controlrad.com

References

1.  https://www.fda.gov/radiation-emitting-products/initiative-reduce-unnecessary-radiation-exposure-medical-imaging/white-paper-initiative-reduce-unnecessary-radiation-exposure-medical-imaging, p. 1

2. Ibid, p. 3

3. Data on file


Related Content

News | Cardiac Imaging

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Time May 02, 2025
arrow
News | Digital Radiography (DR)

Feb. 12, 2025 — Konica Minolta Healthcare Americas, has published a case study by clinicians in the pulmonary and ...

Time February 14, 2025
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
News | Cybersecurity

June 19, 2024 —Karamba Security, a world leader in end-to-end product security, today announced the signing of a ...

Time June 19, 2024
arrow
News | FDA

May 30, 2024 — Vuze Medical, which develops medical technology to transform intra-operative guidance in spinal ...

Time May 30, 2024
arrow
News | Cardiac Imaging

May 17, 2024 — The Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting found that the ...

Time May 17, 2024
arrow
News | Mammography

May 6, 2024 — Enable Me, a VELA Medical company, cited major new research by Siemens Healthineers entitled, “The future ...

Time May 06, 2024
arrow
News | FDA

April 23, 2024 — Royal Philips , a global leader in health technology, today announced its Philips Zenition 30 mobile C ...

Time April 23, 2024
arrow
News | FDA

March 21, 2024 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the CIARTIC Move ...

Time March 21, 2024
arrow
News | Artificial Intelligence

March 6, 2024 — Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced the successful validation ...

Time March 06, 2024
arrow
Subscribe Now